DE60031539D1 - Mutiertes nurr1 gen - Google Patents
Mutiertes nurr1 genInfo
- Publication number
- DE60031539D1 DE60031539D1 DE60031539T DE60031539T DE60031539D1 DE 60031539 D1 DE60031539 D1 DE 60031539D1 DE 60031539 T DE60031539 T DE 60031539T DE 60031539 T DE60031539 T DE 60031539T DE 60031539 D1 DE60031539 D1 DE 60031539D1
- Authority
- DE
- Germany
- Prior art keywords
- relates
- well
- nurr1
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 101001109698 Homo sapiens Nuclear receptor subfamily 4 group A member 2 Proteins 0.000 title 1
- 102100022676 Nuclear receptor subfamily 4 group A member 2 Human genes 0.000 title 1
- 230000035772 mutation Effects 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 208000028017 Psychotic disease Diseases 0.000 abstract 2
- 102220559266 Uncharacterized protein C1orf105_M97V_mutation Human genes 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102220083585 rs375390467 Human genes 0.000 abstract 2
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 101150026563 NR4A2 gene Proteins 0.000 abstract 1
- 238000004113 cell culture Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009261 transgenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Amplifiers (AREA)
- Soil Working Implements (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902489A SE9902489D0 (sv) | 1999-06-30 | 1999-06-30 | Mutated Nurr1 gene |
| SE9902489 | 1999-06-30 | ||
| PCT/SE2000/001380 WO2001000807A1 (en) | 1999-06-30 | 2000-06-29 | MUTATED Nurr1 GENE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60031539D1 true DE60031539D1 (de) | 2006-12-07 |
| DE60031539T2 DE60031539T2 (de) | 2007-06-21 |
Family
ID=20416309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60031539T Expired - Fee Related DE60031539T2 (de) | 1999-06-30 | 2000-06-29 | Mutiertes nurr1 gen |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1194537B1 (de) |
| AT (1) | ATE343632T1 (de) |
| AU (1) | AU6039400A (de) |
| DE (1) | DE60031539T2 (de) |
| ES (1) | ES2273709T3 (de) |
| SE (1) | SE9902489D0 (de) |
| WO (1) | WO2001000807A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005284693B2 (en) * | 2004-09-16 | 2010-04-29 | Paul Michael Shillington | Centralised online ordering and fulfilment method and system |
| US8121858B2 (en) | 2008-03-24 | 2012-02-21 | International Business Machines Corporation | Optimizing pharmaceutical treatment plans across multiple dimensions |
| US10318877B2 (en) | 2010-10-19 | 2019-06-11 | International Business Machines Corporation | Cohort-based prediction of a future event |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5783680A (en) * | 1993-10-06 | 1998-07-21 | The General Hospital Corporation | Genetic diagnosis and treatment for impulsive aggression |
-
1999
- 1999-06-30 SE SE9902489A patent/SE9902489D0/xx unknown
-
2000
- 2000-06-29 AT AT00946672T patent/ATE343632T1/de not_active IP Right Cessation
- 2000-06-29 WO PCT/SE2000/001380 patent/WO2001000807A1/en active IP Right Grant
- 2000-06-29 AU AU60394/00A patent/AU6039400A/en not_active Abandoned
- 2000-06-29 ES ES00946672T patent/ES2273709T3/es not_active Expired - Lifetime
- 2000-06-29 DE DE60031539T patent/DE60031539T2/de not_active Expired - Fee Related
- 2000-06-29 EP EP00946672A patent/EP1194537B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001000807A8 (en) | 2001-04-19 |
| EP1194537B1 (de) | 2006-10-25 |
| WO2001000807A1 (en) | 2001-01-04 |
| AU6039400A (en) | 2001-01-31 |
| SE9902489D0 (sv) | 1999-06-30 |
| EP1194537A1 (de) | 2002-04-10 |
| ES2273709T3 (es) | 2007-05-16 |
| DE60031539T2 (de) | 2007-06-21 |
| ATE343632T1 (de) | 2006-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG142154A1 (en) | Methods for genomic analysis | |
| ATE549347T1 (de) | Gene von säugetiere, und damit verbundene reagentien, methoden | |
| ATE361067T1 (de) | Naphtoquinone derivate als inhibitoren von tau aggregation zur behandlung von alzheimer's und verbundenen neurodegenerativen erkrankungen | |
| MXPA05014215A (es) | Mapeo de genoma de elementos funcionales de adn y proteinas celulares. | |
| ATE540129T1 (de) | Target zur therapie kognitiver behinderungen | |
| AU2003219085A1 (en) | Methods for diagnosing and treating schizophrenia | |
| ECSP088262A (es) | Proteínas de fusión de albúmina | |
| WO2002031134A3 (en) | Novel serine protease genes related to dppiv | |
| DE69932599D1 (de) | Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten | |
| IL176479A0 (en) | Methods and compositions for identifying rna-binding proteins | |
| ATE466080T1 (de) | Formulierungen und verfahren zum denaturieren von proteinen | |
| DE60023860D1 (de) | Verfahren zur herstellung von rekombinanten peptiden | |
| MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
| DE60109430D1 (de) | An entzündlichen darmerkrankungen beteiligte gene und deren verwendung | |
| DK1373502T3 (da) | Dopaminerge neuronale overlevelsesfremmende faktorer og avendelser heraf | |
| DE69928395D1 (de) | Cyclin-e2 proteine und dafür kodierende gene | |
| ATE251886T1 (de) | Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit | |
| DE60031539D1 (de) | Mutiertes nurr1 gen | |
| ATE365807T1 (de) | Hepatitis b virus vektoren für gentherapie | |
| WO2002046767A3 (en) | Diagnosis and treatment of alzheimer's disease | |
| BR0113099A (pt) | Gene e proteìna relacionados com esquizofrenia | |
| SE0301987D0 (sv) | New polypeptide | |
| ATE408708T1 (de) | Mutationen in verbindung mit eisenerkrankungen | |
| ATE318922T1 (de) | Zielgerichtete integration in chromosomen mittels retroviraler vektoren | |
| EA200700346A1 (ru) | Бактериофаг- и профаг-специфические протеины в генной терапии рака |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |